Mutation profiling by targeted sequencing of “triple‐negative” essential thrombocythaemia patients
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Haematology"
DOI: 10.1111/bjh.14723
Abstract: Burger, J.A., Tedeschi, A., Barr, P.M., Robak, T., Owen, C., Ghia, P., Bairey, O., Hillmen, P., Bartlett, N.L., Li, J., Simpson, D., Grosicki, S., Devereux, S., McCarthy, H., Coutre, S., Quach, H., Gaidano, G., Maslyak,… read more here.
Keywords: medicine; profiling targeted; mutation profiling; sequencing triple ... See more keywords
Canadian profiling and targeted agent utilization trial (CAPTUR/PM.1): A phase II basket precision medicine trial.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.tps12127
Abstract: TPS12127Background: Genomic profiling of cancers is increasingly used to refine prognostication and aid in treatment decisions by allowing matching of targeted agents to specific genetic variants. ... read more here.
Keywords: medicine; profiling targeted; trial; targeted agent ... See more keywords
Prioritizing mutational profiling for targeted therapy of lung adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2019.02.29
Abstract: The Lung Cancer Mutation Consortium (LCMC) was launched as a cross-institutional effort to prospectively follow non-small cell lung cancer (NSCLC) patients across sixteen centers in the US, with a focus on genomic mutation profiles, in… read more here.
Keywords: lung; mutational profiling; prioritizing mutational; profiling targeted ... See more keywords